Cohance Lifesciences Limited
NSE: COHANCE.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yann D'Herve
- Employees
- 1,193
- Headquarters
- Hyderabad, India
- IPO year
- 2020
- Market cap
- ₹186.8B
- Website
- https://www.cohance.com
Loading COHANCE…
Loading profile data…Frequently asked questions about COHANCE
What does Cohance Lifesciences Limited (COHANCE.NS) do?
Cohance Lifesciences Limited is a Hyderabad-based pharmaceutical company specializing in contract development and manufacturing (CDMO) services, active pharmaceutical ingredients (APIs), and specialty chemicals. The company was formerly known as Suven Pharmaceuticals Limited and underwent a rebranding following its merger with Cohance Lifescienc...
Where does COHANCE.NS trade?
Cohance Lifesciences Limited (COHANCE.NS) trades on the National Stock Exchange of India.
What sector is COHANCE.NS in?
Cohance Lifesciences Limited (COHANCE.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Cohance Lifesciences Limited?
Yann D'Herve is the chief executive officer of Cohance Lifesciences Limited (COHANCE.NS).
Where is Cohance Lifesciences Limited headquartered?
Cohance Lifesciences Limited is headquartered in India.
Does COHANCE.NS pay a dividend?
Cohance Lifesciences Limited (COHANCE.NS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did COHANCE.NS go public?
Cohance Lifesciences Limited (COHANCE.NS) completed its initial public offering in 2020.